Black patients had a greater risk of TP53 mutation in bile duct, breast, and endometrial cancers, APC mutations in colorectal and ovarian cancers, and KRAS in colon and skin cancers (Fig. 3B–D). This evidence concerns the gene KRAS and ovarian carcinoma.